Lancet study finds no benefit for hydroxychloroquine in COVID-19 patients

The scientists said these drugs should not be used to treat COVID-19 patients outside of clinical trials until results from randomised clinical trials are available to confirm their safety and efficacy for COVID-19 patients. They explained chloroquine, an antimalarial drug and its analogue, hydroxychloroquine, are commonly used to treat autoimmune diseases.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3cUidtf
via IFTTT